Head-to-head · WeighScore
Direct Meds vs RX Bella
The verdict
Direct Meds takes it — 77.6/100 to 67.8/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Direct Meds | RX Bella |
|---|---|---|
| WeighScore | 77.6/100 | 67.8/100 |
| Grade | C+ | C |
| Scorecard rank | #36 | #173 |
| Semaglutide | $249/mo sublingual · $297/mo injectable | From $249/mo (a floor, not a rate) |
| Tirzepatide | $299/mo sublingual · $399/mo injectable | From $299/mo (a floor, not a rate) |
| Coverage | Not publicly listed | Nationwide telehealth, claimed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #36 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Graded #173 · C
Strengths
- All four programs — microdose, oral, semaglutide injection, tirzepatide injection — carry a figure on the homepage before any intake
- Nothing in the catalog is struck through: no invented "was" price and no expiring offer
- "$0 if you're not approved" is stated plainly and repeatedly
- The online provider visit, prescription, delivery and ongoing check-ins are stated as included
Where it loses points
- The hero's "from $199/mo" is the microdose; the tirzepatide program is $299
- Every figure is a floor, no dose ladder is published, and the eight-screen intake reaches an email gate without showing a price
- Its own treatment pages carry no dollar figure and read "AVAILABLE BY CONSULTATION"
- No lab or monitoring requirement is published
- The compounding pharmacies are never named and the footer names no company
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.